🇺🇸 FDA
Patent

US 10647661

Carboxamides as modulators of sodium channels

granted A61KA61K31/165

Quick answer

US patent 10647661 (Carboxamides as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
106
CPC classes
A61K, A61K31/165